R1 RCM Future Growth

Future criteria checks 4/6

R1 RCM is forecast to grow earnings and revenue by 54.2% and 11.2% per annum respectively. EPS is expected to grow by 54% per annum. Return on equity is forecast to be 3.2% in 3 years.

Key information

54.2%

Earnings growth rate

54.0%

EPS growth rate

Healthcare earnings growth	17.2%
Revenue growth rate	11.2%
Future return on equity	3.2%
Analyst coverage	Good
Last updated	31 May 2024

Recent future growth updates

Recent updates

R1 RCM Inc. (NASDAQ:RCM) Shares Could Be 40% Below Their Intrinsic Value Estimate

Jun 05

R1 RCM Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 06

R1 RCM (NASDAQ:RCM) Might Have The Makings Of A Multi-Bagger

Mar 17

Is R1 RCM Inc. (NASDAQ:RCM) Trading At A 42% Discount?

Jan 06

R1 RCM slides 7% on secondary stock offering by selling shareholder

Sep 08

R1 RCM's (NASDAQ:RCM) Promising Earnings May Rest On Soft Foundations

Aug 11

R1 RCM GAAP EPS of -$0.07 misses by $0.11, revenue of $391.9M in-line

Aug 03

R1 RCM: Long-Term Growth Story Intact Following Cloudmed Acquisition

Jul 19

News Flash: Analysts Just Made A Meaningful Upgrade To Their R1 RCM Inc. (NASDAQ:RCM) Forecasts

Jun 30

R1 RCM draws bullish views at Barclays on Cloudmed acquisition

Jun 29

Earnings and Revenue Growth Forecasts

NasdaqGS:RCM - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	3,213	123	407	583	10
12/31/2025	2,920	80	266	400	16
12/31/2024	2,612	-73	180	301	15
3/31/2024	2,313	-33	229	332	N/A
12/31/2023	2,254	3	238	340	N/A
9/30/2023	2,212	-35	151	251	N/A
6/30/2023	2,135	-65	68	168	N/A
3/31/2023	1,966	-91	-93	13	N/A
12/31/2022	1,806	-63	-103	-10	N/A
9/30/2022	1,672	-1	-95	-2	N/A
6/30/2022	1,556	45	-13	63	N/A
3/31/2022	1,518	91	189	242	N/A
12/31/2021	1,475	-505	205	257	N/A
9/30/2021	1,404	-495	190	230	N/A
6/30/2021	1,332	-512	108	145	N/A
3/31/2021	1,293	-526	62	107	N/A
12/31/2020	1,270	47	11	60	N/A
9/30/2020	1,256	14	61	121	N/A
6/30/2020	1,250	16	55	115	N/A
3/31/2020	1,231	3	-16	43	N/A
12/31/2019	1,186	-9	53	114	N/A
9/30/2019	1,135	-22	11	68	N/A
6/30/2019	1,084	-42	33	83	N/A
3/31/2019	997	-41	54	99	N/A
12/31/2018	869	-64	-15	18	N/A
9/30/2018	746	-99	-4	19	N/A
6/30/2018	619	-88	-3	23	N/A
3/31/2018	510	-92	11	39	N/A
12/31/2017	450	-76	N/A	21	N/A
9/30/2017	416	-28	N/A	-22	N/A
6/30/2017	418	-3	N/A	-57	N/A
3/31/2017	327	-36	N/A	-116	N/A
12/31/2016	593	65	N/A	-87	N/A
9/30/2016	555	68	N/A	-100	N/A
6/30/2016	445	17	N/A	-57	N/A
3/31/2016	458	35	N/A	-8	N/A
12/31/2015	117	-84	N/A	-24	N/A
9/30/2015	96	-107	N/A	-39	N/A
6/30/2015	171	-65	N/A	-23	N/A
3/31/2015	208	-55	N/A	-71	N/A
12/31/2014	210	-80	N/A	-77	N/A
9/30/2014	247	-56	N/A	-22	N/A
6/30/2014	174	-103	N/A	-47	N/A
3/31/2014	490	102	N/A	28	N/A
12/31/2013	505	130	N/A	54	N/A
9/30/2013	-220	0	N/A	52	N/A
6/30/2013	-16	41	N/A	51	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RCM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: RCM is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: RCM is expected to become profitable in the next 3 years.

Revenue vs Market: RCM's revenue (11.2% per year) is forecast to grow faster than the US market (8.4% per year).

High Growth Revenue: RCM's revenue (11.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: RCM's Return on Equity is forecast to be low in 3 years time (3.2%).

R1 RCM Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

R1 RCM Inc. Revises Earnings Guidance for the Year 2024

Consensus EPS estimates upgraded to US$0.0021 loss

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024

Price target decreased by 8.8% to US$19.53

R1 RCM Inc. Provides Revenue Guidance for the Year 2023

Price target increased by 7.8% to US$21.70

Recent updates

R1 RCM Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

R1 RCM Inc., Annual General Meeting, May 22, 2024

R1 RCM Inc. to Report Q1, 2024 Results on May 08, 2024

Consensus EPS estimates upgraded to US$0.0021 loss

Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment

New minor risk - Earnings quality

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024

New Mountain Partners V (AIV-D), L.P. and New Mountain Investments V, L.L.C., managed by New Mountain Capital, L.L.C. submits a non-binding proposal to acquire remaining 67.56906% stake in R1 RCM Inc. (NasdaqGS:RCM) from TowerBrook Investors, Ltd and others for approximately $4 billion.

Full year 2023 earnings: EPS misses analyst expectations

Coliseum Capital Issues an Open Letter to the Board of R1 RCM

R1 RCM Inc. Appoints Pamela L. Spikner as Principal Accounting Officer

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of Acclara Solutions, LLC from Providence St. Joseph Health for $680 million.

R1 RCM Inc. to Report Q4, 2023 Results on Feb 27, 2024

R1 RCM Inc. Appoints Clay Ashdown as Director

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Inc. announced delayed 10-Q filing

Price target decreased by 8.8% to US$19.53

R1 RCM Inc. Provides Revenue Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.003 (vs US$0.071 loss in 3Q 2022)

Now 26% undervalued after recent price drop

R1 RCM Inc. Announces Janie Wade Resigns from its Board of Directors

Now 20% undervalued after recent price drop

R1 RCM Inc. to Report Q3, 2023 Results on Nov 02, 2023

Calculating The Fair Value Of R1 RCM Inc. (NASDAQ:RCM)

Returns At R1 RCM (NASDAQ:RCM) Are On The Way Up

Lead Independent Director notifies of intention to sell stock

Price target increased by 7.8% to US$21.70

R1 RCM Inc. Provides Earnings Guidance for the Year of 2023

Second quarter 2023 earnings released: EPS: US$0.001 (vs US$0.069 loss in 2Q 2022)

Is Now An Opportune Moment To Examine R1 RCM Inc. (NASDAQ:RCM)?

R1 RCM Inc. to Report Q2, 2023 Results on Aug 02, 2023

Why We're Not Concerned About R1 RCM Inc.'s (NASDAQ:RCM) Share Price

Senior VP recently sold US$487k worth of stock

R1 RCM Inc. (NASDAQ:RCM) Shares Could Be 40% Below Their Intrinsic Value Estimate

President recently sold US$327k worth of stock

President notifies of intention to sell stock

R1 RCM Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

R1 RCM Inc. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

R1 RCM (NASDAQ:RCM) Might Have The Makings Of A Multi-Bagger

CEO & Director recently bought US$1.0m worth of stock

Full year 2022 earnings: EPS misses analyst expectations

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2023

Price target increased by 7.3% to US$16.18

R1 RCM Inc. to Report Q4, 2022 Results on Feb 16, 2023

Consensus forecasts updated

R1 RCM Inc. Announces Chief Financial Officer Changes

Is R1 RCM Inc. (NASDAQ:RCM) Trading At A 42% Discount?

R1 RCM Inc. Appoints Janie Wade as a Director of the Company, Effective January 1, 2023

R1 RCM Inc. Announces Retirement of Albert Zimmerli from the Board of Directors, Effective January 1, 2023

Price target decreased to US$15.55

Price target decreased to US$27.82

R1 RCM Inc. Provides Earnings Guidance for the Year 2022

R1 RCM Inc. to Report Q3, 2022 Results on Nov 08, 2022

R1 RCM slides 7% on secondary stock offering by selling shareholder

Key Executive recently sold US$1.0m worth of stock

R1 RCM Inc. Appoints Brian Dean as Director

R1 RCM's (NASDAQ:RCM) Promising Earnings May Rest On Soft Foundations

Key Executive exercised options and sold US$1.2m worth of stock

Independent Director recently sold US$270k worth of stock

Second quarter 2022 earnings: EPS misses analyst expectations

R1 RCM Inc. Provides Revenue Guidance for the Full Year of 2022

R1 RCM GAAP EPS of -$0.07 misses by $0.11, revenue of $391.9M in-line

Consensus forecasts updated

R1 RCM Inc. to Report Q2, 2022 Results on Aug 03, 2022